Bortecad 2mg Injection

Bortecad 2mg Injection

Therapeutic Class:
Get Quote

BORTECAD 2MG INJECTION contains Bortezomib, which belongs to the group of medicines called Antineoplastic agents. It is used in adult patients alone or with pegylated liposomal doxorubicin/dexamethasone to manage progressive multiple myeloma when anticancer therapy or hematopoietic stem cell transplantation becomes unsuitable to manage the disease.

BORTECAD 2MG INJECTION is also used in adult patients with rituximab, cyclophosphamide, doxorubicin, and prednisone to manage untreated mantle cell lymphoma when hematopoietic stem cell transplantation becomes unsuitable to manage the disease.

Multiple myeloma is a type of cancer that occurs in plasma cells (white blood cells) and is generally characterized by symptoms such as bone pain, nausea, constipation, and loss of appetite. Mantle Cell Lymphoma is a rare form of cancer that affects the lymphatic system and is generally characterized by symptoms such as loss of appetite, fever, nausea, and/or vomiting.

Your doctor may advise you to do regular blood tests to check your blood counts before and during management with BORTECAD 2MG INJECTION. It is not recommended for use in patients with severe lung or heart disease.

Before receiving BORTECAD 2MG INJECTION, inform your doctor if you have bleeding problems, diarrhea, constipation, nausea or vomiting, shortness of breath or cough, seizures, congestive heart failure, mild or moderate renal impairment, and/or moderate or severe liver impairment.

BORTECAD 2MG INJECTION is not recommended for use by pregnant and breastfeeding women. BORTECAD 2MG INJECTION is also not indicated for use in children and adolescents (below 18 years of age).

The most common side effects of receiving BORTECAD 2MG INJECTION are dizziness, increased heartbeat, sweating, abnormal vision, paresthesia (burning or pickling sensation), muscle pain, and headache. Inform your doctor if any of the symptoms worsen during or after management with BORTECAD 2MG INJECTION.

Salt Composition: Bortezomib
Strength: (2mg)
Pack Size: 1.0 Injection in 1 vial
Uses: Multiple myeloma Mantle-cell lymphoma
Table Header
Salt Composition
Bortezomib
Strength
(2mg)
Pack Size
1.0 Injection in 1 vial
Uses
Multiple myeloma Mantle-cell lymphoma
SKU 8e00adf2a01f Category
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Bortecad 2mg Injection which is also known as Bortezomib and Manufactured by Cadila Pharmaceuticals Ltd. It is available in strength of 2mg is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:
×